A venture capital firm based in Canada provides equity capital to portfolio companies and is very flexible in the size of investments it makes, placing a high emphasis on innovation of potential portfolio companies. The firm is currently investing in Canadian companies only, with no set limit on the amount of funds or number of investments.
The firm is looking to invest primarily in innovative green technology as well as biotech therapeutics and medical technology, and is also open to looking at companies in diagnostics and healthcare IT. The firm will consider products of any stage of development, from pre-clinical to phase III as long as the company’s product displays high potential to positively impact the environment or healthcare. In addition, the firm is agnostic to indication and will look at anything that fits in the environment or healthcare sectors.
The firm has taken a board seat in its portfolio companies before, but this is not required by the firm. The companies do not need to have an experienced management team, as innovation is the most important factor that the firm expects from companies. The firm prefers to act as the lead investor, but is open to co-investing with other firms that share the firm’s interests.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org